Sparrow Cancer Center has a clinical trial underway that is offering new hope to cancer patients.
The trial works by using genetic test results to match patients with a targeted cancer drug. People with different types and stages of some cancers who are no longer getting a benefit from standard treatments may be eligible to participate in the trial.
News 10's Scott Wolchek is speaking with doctors and patients about what this could mean for cancer patients in Mid-Michigan.
